Results 331 to 340 of about 269,977 (355)
Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy. [PDF]
Front ImmunolWang J +10 more
europepmc +1 more source
Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines. [PDF]
BME FrontSong K, Pun SH.
europepmc +1 more source
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma [PDF]
, 2019 Artyomov, Maxim N. +15 more
core +1 more source
Analysis of physical and biological delivery systems for DNA cancer vaccines and their translation to clinical development. [PDF]
Clin Exp Vaccine ResOelkrug C.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Seminars in Oncology Nursing, 2003
To provide a review of cancer vaccines, how they work, and the current state of the science underlying these treatments.Research studies, review articles, book chapters, personal communications.Vaccines have been studied in a variety of malignancies; however, melanoma has provided the best tumor model for vaccination.
Paula M, Muehlbauer +1 more
+7 more sources
To provide a review of cancer vaccines, how they work, and the current state of the science underlying these treatments.Research studies, review articles, book chapters, personal communications.Vaccines have been studied in a variety of malignancies; however, melanoma has provided the best tumor model for vaccination.
Paula M, Muehlbauer +1 more
+7 more sources
Current Protocols in Human Genetics, 1997
AbstractThis unit describes the use of retroviral vectors that can be successfully employed for gene transfer into both primary tumor cultures and established cell lines. The unit includes procedures for assaying the stability of the vaccine following gene transfer.
Elizabeth M. Jaffee, Tim F. Greten
openaire +6 more sources
AbstractThis unit describes the use of retroviral vectors that can be successfully employed for gene transfer into both primary tumor cultures and established cell lines. The unit includes procedures for assaying the stability of the vaccine following gene transfer.
Elizabeth M. Jaffee, Tim F. Greten
openaire +6 more sources
Nature Reviews Cancer, 2021
Therapeutic cancer vaccines have undergone a resurgence in the past decade. A better understanding of the breadth of tumour-associated antigens, the native immune response and development of novel technologies for antigen delivery has facilitated improved vaccine design.
Saxena, M. +3 more
openaire +3 more sources
Therapeutic cancer vaccines have undergone a resurgence in the past decade. A better understanding of the breadth of tumour-associated antigens, the native immune response and development of novel technologies for antigen delivery has facilitated improved vaccine design.
Saxena, M. +3 more
openaire +3 more sources
Scientific American, 2016
The article focuses on research into the development of vaccines using cancer cell DNA to help eliminate tumors and prevent cancer recurrence. It states researchers have found methods of encouraging the immune system to focus on proteins unique to cancerous tissues.
Elaine R. Mardis, Beatriz M. Carreno
openaire +3 more sources
The article focuses on research into the development of vaccines using cancer cell DNA to help eliminate tumors and prevent cancer recurrence. It states researchers have found methods of encouraging the immune system to focus on proteins unique to cancerous tissues.
Elaine R. Mardis, Beatriz M. Carreno
openaire +3 more sources